Reading this on a mobile device? Try our optimized mobile version here:

February 14, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
  • Team in Japan clears hurdle on way to trial of iPS cells
    An ethics panel at the Institute for Biomedical Research and Innovation in Japan has given the green light for a clinical trial of induced pluripotent stem cells in the treatment of age-related macular degeneration. If Japan's Health Ministry approves the six-patient trial, it could begin this fiscal year. The Japan Daily Press (2/14) LinkedInFacebookTwitterEmail this Story
Patient Blood Management Resources from AABB
AABB offers a host of tools for transfusion decision makers. Clinical guidelines, education sessions and more. AABB Members can download Getting Started in Patient Blood Management and Citations in Patient Blood Management for FREE. Visit for more information.

  Science & Health 
  • Potential as vision loss therapy seen in adult stem cells
    A subretinal injection of human adult stem cells may be a viable treatment for patients with vision loss as a result of geographic atrophy, according to findings presented at an angiogenesis symposium. After the 18-patient study, researchers hope to find biomarkers that would help predict which patients will benefit from treatment. Healio (2/13) LinkedInFacebookTwitterEmail this Story
  • Treatment shows promise as adjunctive calciphylaxis therapy
    Thrombolytic tissue plasminogen activator was associated with a 30% increase in the survival rate for patients with calciphylaxis, according to a study in the journal JAMA Dermatology. Complications included major and minor bleeding, and six out of 15 patients had blood transfusions. Healio (2/13) LinkedInFacebookTwitterEmail this Story
  • Video capsules can detect GI bleeding in emergencies
    A pilot study explored the possibility that emergency department doctors could use video capsule endoscopy to find bleeds in the upper gastrointestinal tract. Two gastroenterologists and two emergency department doctors agreed in the assessment of more than 90% of images, according to a report in the Annals of Emergency Medicine. The study was not intended to support a change in practice but could lead to further research. (2/12) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • IOM: Tracking system needed to curb sales of fake drugs
    The Institute of Medicine has called for a national drug-tracking system following an FDA warning on counterfeit Avastin. Such a system might utilize barcodes or electronic tags to confirm the authenticity of a medication and the ingredients used during its production, an expert said. FDA Commissioner Dr. Margaret Hamburg lauded the report. CBS News/The Associated Press (2/13) LinkedInFacebookTwitterEmail this Story
  • HHS encourages e-patients with new effort
    HHS announced plans to create a broad shift to a less hierarchical health care system, giving patients and families a greater role in their own care. A new initiative aims to expand patients' access to EHRs, mobile health applications and devices, and secure electronic messaging between patients and providers, according to an article published in the journal Health Affairs. "Engaged patients ... are more likely than others to participate in preventive and healthy practices, self-manage their conditions and achieve better outcomes," said National Health IT Coordinator Dr. Farzad Mostashari. Politico (Washington, D.C.) (2/11) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • New chief executive to lead Nanosphere
    Nanosphere, a maker of testing products for gram-positive blood and respiratory infections, appointed Michael McGarrity as president and CEO. He was previously the company's vice president of sales and marketing. Among other changes, Sheli Rosenberg joined Nanosphere's board and will serve as its chairman. GenomeWeb Daily News (free registration) (2/14) LinkedInFacebookTwitterEmail this Story

On-line SBB Exam Review Course offered through The George Washington University
Self-paced preparation for the ASCP SBB certification exam. Application deadlines: February 1, June 1 and September 1. Main exam content categories covered. Includes sample exam questions. Contact course director, William Turcan, at for more information.

  Government & Regulatory 
  • FDA updates watch list
    The FDA added GlaxoSmithKline's leukemia drug Arzerra, or ofatumumab; UCB's epilepsy, liver and kidney drug Vimpat, or lacosamide; and Acorda Therapeutics' multiple sclerosis, kidney and liver drug Ampyra, or dalfampridine, to its list of products to monitor due to new safety information or possible signals of serious risks. The FDA received reports of potential adverse events involving the treatments in last year's third quarter. Medscape (free registration) (2/12) LinkedInFacebookTwitterEmail this Story
  • Medical device issues prompt FDA notice to Hospira
    Hospira said it has received a notice from the FDA over certain quality concerns involving its medical devices. CEO F. Michael Ball said that while inspectors noted progress had been made, "there is still a lot of work to be done within our device operations." Reuters (2/13) LinkedInFacebookTwitterEmail this Story
  Association News 
  • Restrictive transfusion strategy may benefit patients with acute upper gastrointestinal bleeding
    A video posted on highlights a study showing that a restrictive red blood cell transfusion strategy may lead to better outcomes than a liberal strategy for patients with acute upper gastrointestinal bleeding. In the study, the restrictive strategy was characterized by a transfusion being administered only when a patient's hemoglobin level fell below 7 grams per deciliter. According to researchers, this strategy was associated with decreased mortality, a reduction in bleeding, shortened hospital stays and fewer adverse events overall. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Donor Collections DirectorBlood Centers of the PacificUS - CA - San Francisco
Medical Technologist CLS - Cord Blood ProgramSan Diego Blood BankUS - CA - San Diego
Click here to view more job listings.

Mistakes are part of the dues that one pays for a full life."
--Sophia Loren,
Italian actress

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Jennifer Garfinkel

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information